CurrentmhnPolicy N/A

Clinical Policy: Homocysteine Testing

Clinical policy governing the medical necessity and coverage considerations for homocysteine laboratory testing for Health Plan members; applies to providers submitting claims to the Health Plan.

Policy Summary

Payermhn

PolicyHomocysteine Testing (Clinical Policy)

Policy CodePolicy N/A

Change TypeNo material change

Effective DateN/A

Next Review DateN/A

Key ActionReview Medicare NCDs and LCDs for consistency and follow member coverage documents when applying this policy.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

Centenepolicy owner

2018copyright

Medicaid/Medicarenotes

Coverage Criteria

Coverage decisions and the administration of benefits are governed by the member's coverage documents and applicable law. This clinical policy is provided to guide medical necessity determinations but does not replace the terms, conditions, exclusions, and limitations set forth in the member's evidence of coverage, certificate of coverage, policy, or contract; failure to meet those provisions may result in claim denial or benefit ineligibility. Providers must follow the Health Plan's coverage documents when submitting claims and administering benefits.

This clinical policy is not medical advice and does not dictate how providers must practice medicine. Providers are expected to exercise their own professional medical judgment in diagnosing and treating members and remain solely responsible for the medical care and advice they provide. Members should consult their treating physician for diagnosis and treatment decisions.

Covered Indications for Homocysteine Testing

No specific covered indications for homocysteine testing are identified in the available excerpt.

Covered indications: None specified in the policy excerpt; refer to applicable state Medicaid provisions, Medicare NCDs/LCDs, and the member's coverage documents for determinations.

Provider Actions and Responsibilities

Policy Summary

Payermhn

PolicyHomocysteine Testing (Clinical Policy)

Policy CodePolicy N/A

Change TypeNo material change

Effective DateN/A

Next Review DateN/A

Key ActionReview Medicare NCDs and LCDs for consistency and follow member coverage documents when applying this policy.

SourceLink

On This Page

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Note

Regulatory Consistency and Precedence

Note: For Medicare members/enrollees, to ensure regulatory consistency and precedence, all applicable Medicare National Coverage Determinations (NCDs), Local Coverage Determinations (LCDs), and Medicare Coverage Articles should be reviewed and applied prior to using this policy. Refer to the CMS website at http://www.cms.gov for additional information.

Documentation Required

Coverage Document Compliance

Providers must follow all terms, conditions, exclusions, and limitations of the member's coverage documents (e.g., evidence of coverage, certificate of coverage, policy, contract of insurance) when administering benefits or submitting claims. Coverage decisions and benefit administration are subject to state and federal requirements and applicable Health Plan administrative policies and procedures. For Medicaid members/enrollees, when state Medicaid coverage provisions conflict with this clinical policy, state Medicaid provisions take precedence; refer to the applicable state Medicaid manual.

Note

Provider Responsibilities Reminder

This clinical policy was developed by qualified healthcare professionals using current standards of medical practice and available clinical evidence. It is a guide to medical necessity and does not constitute a contract or guarantee of payment. The Health Plan may change, amend, or withdraw this clinical policy at any time. Providers and their representatives agree to be bound by Health Plan terms and may be subject to additional Health Plan-level administrative policies and procedures when providing services or submitting claims for payment.

Definitions

inv-08: Clinical policy definition

DefinitionClinical policy: guidance to assist in making medical necessity and coverage decisions based on review of accepted standards, peer-reviewed literature, guidelines, and expert opinion; it is not a contract or guarantee of payment.

Role of providersProviders are expected to exercise professional medical judgment and remain solely responsible for medical advice, treatment and care of members.

Legal/coverage statusThis clinical policy does not constitute medical advice, dictate practice, nor guarantee payment; coverage decisions are subject to the member's coverage documents and applicable state/federal requirements.

PrecedenceState Medicaid provisions take precedence over this clinical policy when they conflict; Medicare NCDs/LCDs should be reviewed for consistency prior to applying this policy.

LimitationsThe Health Plan may change, amend or withdraw this clinical policy; effective date is determined by the Health Plan and may differ from posting date.

OpenPayer

Clinical Policy: Homocysteine Testing

Coverage Criteria

Provider Actions and Responsibilities

Ordering Requirements

Not Covered / Exclusions

Frequency Limits

Definitions

Background